NewslettersMammary Cell NewsUncategorizedMCL-1 Is a Clinically Targetable Vulnerability in Breast CancerBy Justin.choi - March 31, 20220171On-target compounds specific to MCL-1 have demonstrated promising efficacy in preclinical models of breast cancer and show potential to enhance the anti-tumor effect of conventional therapies.[Cell Cycle] 6445212 AAAAAAAA items 1 apa 0 default asc 1 173499 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract